14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Turning a blind eye – one-off act not a PCP - In Ishola v Transport for London the Court of Appeal...
Read More >
The beauty of the retirement plan business is that it’s constantly changing, the bad part of it is ...
Read More >
As countries emerge from lockdown, talk turns to The Return of COVID-19. Here’s how to succeed in f...
Read More >
If you haven’t heard the phrase “OK Boomer” yet, you probably are a boomer – a baby boomer. And ...
Read More >
In this episode of The Proskauer Brief, partners Tony Oncidi and Kate Gold discuss California’s mos...
Read More >
The long awaited overhaul of the Unit Titles Act 2010 has moved one step further with the Unit Title...
Read More >